West Oak Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-65
Closed -$58 311
2025
Q1
$58 Hold
65
﹤0.01% 254
2024
Q4
$52K Hold
65
﹤0.01% 260
2024
Q3
$59 Sell
65
-420
-87% -$35.3K ﹤0.01% 261
2024
Q2
$38.2K Sell
485
-3,765
-89% -$309K 0.02% 194
2024
Q1
$370K Sell
4,250
-1,145
-21% -$97.7K 0.16% 88
2023
Q4
$472K Sell
5,395
-1,590
-23% -$121K 0.22% 79
2023
Q3
$547K Hold
6,985
0.27% 76
2023
Q2
$615K Sell
6,985
-405
-5% -$34.9K 0.3% 74
2023
Q1
$596K Sell
7,390
-160
-2% -$13K 0.3% 75
2022
Q4
$587K Sell
7,550
-8,447
-53% -$685K 0.31% 73
2022
Q3
$1.29M Buy
15,997
+2,820
+21% +$253K 0.7% 56
2022
Q2
$1.18M Buy
13,177
+487
+4% +$49.3K 0.62% 60
2022
Q1
$1.41M Buy
12,690
+3,435
+37% +$363K 0.64% 59
2021
Q4
$957K Sell
9,255
-4,109
-31% -$476K 0.35% 66
2021
Q3
$1.68M Buy
13,364
+1,210
+10% +$157K 0.65% 57
2021
Q2
$1.51M Buy
12,154
+375
+3% +$47.1K 0.59% 59
2021
Q1
$1.39M Buy
11,779
+140
+1% +$16.4K 0.59% 58
2020
Q4
$1.36M Buy
11,639
+9,555
+458% +$1.05M 0.63% 56
2020
Q3
$217K Hold
2,084
0.12% 106
2020
Q2
$191K Hold
2,084
0.11% 107
2020
Q1
$188K Hold
2,084
0.13% 105
2019
Q4
$236K Hold
2,084
0.13% 105
2019
Q3
$226K Buy
2,084
+277
+15% +$28.9K 0.13% 101
2019
Q2
$176K Buy
1,807
+466
+35% +$42.5K 0.11% 115
2019
Q1
$122K Hold
1,341
0.08% 130
2018
Q4
$122K Hold
1,341
0.09% 126
2018
Q3
$132K Hold
1,341
0.08% 133
2018
Q2
$115K Hold
1,341
0.07% 136
2018
Q1
$108K Hold
1,341
0.06% 145
2017
Q4
$108K Hold
1,341
0.07% 136
2017
Q3
$104K Sell
1,341
-15
-1% -$1.25K 0.06% 150
2017
Q2
$120K Hold
1,356
0.07% 140
2017
Q1
$109K Hold
1,356
0.07% 139
2016
Q4
$96.6K Hold
1,356
0.06% 147
2016
Q3
$117K Buy
1,356
+634
+88% +$55.2K 0.08% 135
2016
Q2
$62.6K Hold
722
0.05% 154
2016
Q1
$54.1K Hold
722
0.04% 145
2015
Q4
$55.5K Hold
722
0.04% 145
2015
Q3
$48.3K Hold
722
0.04% 153
2015
Q2
$53.5K Hold
722
0.04% 147
2015
Q1
$56.3K Buy
+722
New +$54.7K 0.04% 144

Other funds holding MDT

West Oak Capital's MDT Position: Q2 2025 in Review

West Oak Capital sold out of Medtronic (MDT) in Q2 2025, closing a stake of 65 shares — an estimated $58 sold.

West Oak Capital first reported a position in MDT in Q1 2015 and held it in 41 quarters. The position peaked at $1.68M in Q3 2021. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

  • West Oak Capital reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
  • West Oak Capital sold 65 Medtronic shares in Q2 2025, an estimated $58.
  • West Oak Capital first reported a position in Medtronic in Q1 2015 and held it in 41 quarters.
  • West Oak Capital's Medtronic position peaked at $1.68M in Q3 2021.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on West Oak Capital's 13F filing for Q2 2025, filed 15 Jul 2025.